Skip to main content

Table 2 Baseline characteristics of patients with CHD and control subjects

From: Impact of matrix metalloproteinase 9 rs3918242 genetic variant on lipid-lowering efficacy of simvastatin therapy in Chinese patients with coronary heart disease

 

Controls (n = 186)

CHD group (n = 264)

Sex (M:F)

96: 90

152: 112

Age (years)

58 ± 10.72

59 ± 11.67

Waist (cm)

86.25 ± 6.03

88.11 ± 5.97

Height (cm)

171.28 ± 5.39

169.15 ± 6.62

Weight (kg)

70.04 ± 7.91

71.24 ± 7.35

Body mass index (kg/m2)

23.98 ± 2.93

24.73 ± 2.86

Systolic blood pressure (mmHg)

123 ± 19

125 ± 21

Diastolic blood pressure (mmHg)

60 ± 17

65 ± 18

Heart rate

64 ± 15

67 ± 16

Fasting glucose (mmol/l)

4.35 ± 1.02

4.62 ± 1.31

Smoking

45 (24.19%)

109 (41.23%)*

Alcohol abuse

26 (14.05%)

43 (16.27%)

  1. Data are means ± SD. *P <0.01 compared with control group. CHD coronary heart disease